Proglicem | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Proglicem
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Contact Supplier

Topscience Biotech specializes in R&D, production, sales of Sodium Hyaluronate, focusing on Cosmetics, Medical, Pharmaceutical Grade HA

Contact Supplier

Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

Contact Supplier

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

China

Contact Supplier

Proglicem

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

19 API Suppliers, 6 USDMF, 2 CEP/COS, 1 JDMF, 1 EU WC, 14 NDC API, 6 Listed Suppliers, $ API Reference Price

19 API Suppliers
6 USDMF
2 CEP/COS
1 JDMF
1 EU WC
14 NDC API
6 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

32 Drugs in Development

32 Drugs in Development

FINISHED DOSAGE FORMULATIONS

20 FDF Dossiers, 11 FDA Orange Book, 3 Europe, 1 Canada, 1 South Africa, 4 Listed Dossiers

20 FDF Dossiers
11 FDA Orange Book
3 Europe
1 Canada
1 South Africa
4 Listed Dossiers

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 2 SPI Pharma, 2 DKSH, 1 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Actylis, 1 Aeon Procare, 1 Ashland, 2 BASF, 1 Finar, 1 Gangwal Chemicals, 1 Kima Chemical, 3 Microlex e.U, 1 Nanjing Bold Chemical, 11 Roquette, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

2 Rochem International Inc
2 SPI Pharma
2 DKSH
1 Gangwal Healthcare
3 Nanjing Well Pharmaceutical
1 Actylis
1 Aeon Procare
1 Ashland
2 BASF
1 Finar
1 Gangwal Chemicals
1 Kima Chemical
3 Microlex e.U
1 Nanjing Bold Chemical
11 Roquette
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries
1 The Dow Chemical Company
1 Valens Pharmachem
1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

13 Film Formers & Plasticizers, 11 Thickeners and Stabilizers, 7 Solubilizers, 6 Coating Systems & Additives, 6 Fillers, Diluents & Binders, 5 Rheology Modifiers, 5 Parenteral, 4 Taste Masking, 4 Topical, 3 Direct Compression, 2 Emulsifying Agents, 2 Chewable & Orodispersible Aids, 1 API Stability Enhancers, 1 Granulation, 1 Soft Gelatin, 1 Lubricants & Glidants, 1 Co-Processed Excipients, 1 Disintegrants & Superdisintegrants

13 Film Formers & Plasticizers
11 Thickeners and Stabilizers
7 Solubilizers
6 Coating Systems & Additives
6 Fillers, Diluents & Binders
5 Rheology Modifiers
5 Parenteral
4 Taste Masking
4 Topical
3 Direct Compression
2 Emulsifying Agents
2 Chewable & Orodispersible Aids
1 API Stability Enhancers
1 Granulation
1 Soft Gelatin
1 Lubricants & Glidants
1 Co-Processed Excipients
1 Disintegrants & Superdisintegrants

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 24 News #PharmaBuzz

1 Data Compilation #PharmaFlow
24 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 4 Regulatory FDF Prices

2 US Medicaid Prescriptions
4 Regulatory FDF Prices

MARKET PLACE

11 APIs, 3 FDF Dossiers

11 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents

12 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 Others

1 EDQM
1 Others

$ API Ref.Price (USD/KG) : 4,673 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

12 All

01 12SOLENO THERAP

filter Patent Number Reset all filters

12 All

01 37572789

02 37799777

03 39757384

04 312178823

filter API Patent Reset all filters

12 All

01 6Y

02 6Blank

filter FDF Patent Reset all filters

12 All

01 3Y

02 9Blank

filter Expiration Date Reset all filters

12 All

01 32026-12-20

02 32029-03-05

03 62035-11-12

Product Main Page

01

SOLENO THERAP

DIAZOXIDE CHOLINE

IMCAS Asia

Not Confirmed

SOLENO THERAP

Country

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-11-12

DIAZOXIDE CHOLINE

US Patent Number : 12178823

Drug Substance Claim :

Drug Product Claim :

Application Number : 216665

Patent Use Code : U-4167

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-11-12

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

SOLENO THERAP

DIAZOXIDE CHOLINE

IMCAS Asia

Not Confirmed

SOLENO THERAP

Country

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-11-12

DIAZOXIDE CHOLINE

US Patent Number : 12178823

Drug Substance Claim :

Drug Product Claim :

Application Number : 216665

Patent Use Code : U-4167

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-11-12

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

SOLENO THERAP

DIAZOXIDE CHOLINE

IMCAS Asia

Not Confirmed

SOLENO THERAP

Country

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-11-12

DIAZOXIDE CHOLINE

US Patent Number : 12178823

Drug Substance Claim :

Drug Product Claim :

Application Number : 216665

Patent Use Code : U-4167

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-11-12

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

SOLENO THERAP

DIAZOXIDE CHOLINE

IMCAS Asia

Not Confirmed

SOLENO THERAP

Country

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-11-12

DIAZOXIDE CHOLINE

US Patent Number : 9757384

Drug Substance Claim :

Drug Product Claim :

Application Number : 216665

Patent Use Code : U-4167

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-11-12

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

SOLENO THERAP

DIAZOXIDE CHOLINE

IMCAS Asia

Not Confirmed

SOLENO THERAP

Country

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-11-12

DIAZOXIDE CHOLINE

US Patent Number : 9757384

Drug Substance Claim :

Drug Product Claim :

Application Number : 216665

Patent Use Code : U-4167

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-11-12

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

SOLENO THERAP

DIAZOXIDE CHOLINE

IMCAS Asia

Not Confirmed

SOLENO THERAP

Country

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-11-12

DIAZOXIDE CHOLINE

US Patent Number : 9757384

Drug Substance Claim :

Drug Product Claim :

Application Number : 216665

Patent Use Code : U-4167

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-11-12

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

SOLENO THERAP

DIAZOXIDE CHOLINE

IMCAS Asia

Not Confirmed

SOLENO THERAP

Country

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-05

DIAZOXIDE CHOLINE

US Patent Number : 7799777

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 216665

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-05

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

SOLENO THERAP

DIAZOXIDE CHOLINE

IMCAS Asia

Not Confirmed

SOLENO THERAP

Country

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-12-20

DIAZOXIDE CHOLINE

US Patent Number : 7572789

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 216665

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-12-20

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

09

SOLENO THERAP

DIAZOXIDE CHOLINE

IMCAS Asia

Not Confirmed

SOLENO THERAP

Country

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-12-20

DIAZOXIDE CHOLINE

US Patent Number : 7572789

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 216665

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-12-20

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

10

SOLENO THERAP

DIAZOXIDE CHOLINE

IMCAS Asia

Not Confirmed

SOLENO THERAP

Country

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-12-20

DIAZOXIDE CHOLINE

US Patent Number : 7572789

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 216665

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-12-20

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!